Among them, lncRNAs PVT1, H19, and UCA1 were proved to involve in gemcitabine resistance in other cancers and CCA progression15–20, suggested that our screen strategy for gemcitabine resistance-related lncRNAs were feasible. This evidence concerns the gene UCA1 and cholangiocarcinoma.